drugset / Trial / NCT03743025
Metabolic Phenotyping During Stress Hyperglycemia in Cardiac Surgery Patients
Phase 4
Terminated
28 enrolled
Emory University
National Institute of General Medical Sciences (NIGMS) · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
This study is a prospective randomized study to examine the effects of exposure to dulaglutide on the prevention of stress-hyperglycemia and the metabolic inflammatory response in the perioperative period.
Timeline
- Start
- 2019-03-08
- Primary completion
- 2023-05-02
- Completion
- 2023-05-02
Outcome
Outcome not reported
Stopped: “The study was terminated following the Data and Safety Monitoring Board (DSMB) review due to concerns with perioperative use of the study drug.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dulaglutide | Peptide | 0.75 mg | — |